시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 매크로라이드계 항생제 시장 규모, 점유율, 성장 분석 : 약제별, 투여법별, 적응증별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Macrolide Antibiotics Market Size, Share, Growth Analysis, By Drugs (Azithromycin, Clarithromycin), By Administration (Oral, Parenteral), By Indication, By End User, By Region - Industry Forecast 2025-2032
상품코드 : 1630766
리서치사 : SkyQuest
발행일 : 2025년 01월
페이지 정보 : 영문 218 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,753,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 9,070,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,387,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

매크로라이드계 항생제 세계 시장 규모는 2023년 58억 달러로 평가되었습니다. 예측 기간(2025-2032년) 동안 2.3%의 연평균 복합 성장률(CAGR)로 2024년 59억 3,000만 달러에서 2032년 71억 2,000만 달러로 성장할 것으로 예상됩니다.

매크로라이드계 항생제 시장은 세계 감염병 유행률 증가에 힘입어 성장이 예상됩니다. 매크로라이드계 항생제는 대환형 락톤 구조와 박테리아의 리보솜에 결합하여 단백질 합성을 억제하는 능력이 특징이며, 성병 및 폐렴-기관지염 등 호흡기 질환을 포함한 다양한 감염 질환에 효과적입니다. 미국 생명공학정보센터(National Centre for Biotechnology Information)에 따르면, 폐렴의 유병률은 세계적으로 인구 1,000명당 1.5-14명, 미국에서는 10,000명당 24.8명으로 상당히 높은 편이며, 특히 노년층에서 유병률이 높습니다. 입니다. 이러한 항생제에 대한 수요 증가는 제네릭 의약품의 가용성에 의해 더욱 촉진되고 있으며, 각 회사들은 오리지널 의약품의 마크로라이드에 상응하는 의약품을 개발하여 시장에서의 입지를 강화하기 위해 노력하고 있습니다.

목차

서론

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

매크로라이드계 항생제 시장 규모 : 약제별 & CAGR(2025-2032년)

매크로라이드계 항생제 시장 규모 : 투여법별 & CAGR(2025-2032년)

매크로라이드계 항생제 시장 규모 : 적응증별 & CAGR(2025-2032년)

매크로라이드계 항생제 시장 규모 : 최종사용자별 & CAGR(2025-2032년)

매크로라이드계 항생제 시장 규모 : 지역별 & CAGR(2025-2032년)

경쟁 정보

주요 기업 개요

결론과 추천 사항

LSH
영문 목차

영문목차

Global Macrolide Antibiotics Market size was valued at USD 5.8 billion in 2023 and is poised to grow from USD 5.93 billion in 2024 to USD 7.12 billion by 2032, growing at a CAGR of 2.3% during the forecast period (2025-2032).

The macrolide antibiotic market is poised for growth, driven by a rising global prevalence of infectious diseases. Macrolides, characterized by their macrocyclic lactone structure and ability to inhibit protein synthesis by binding to the bacterial ribosome, are effective against various infections, including sexually transmitted diseases and respiratory ailments like pneumonia and bronchitis. The National Centre for Biotechnology Information reports significant rates of pneumonia, with incidences ranging from 1.5 to 14 cases per 1,000 people globally, and 24.8 cases per 10,000 in the United States, especially among older adults. The increasing demand for these antibiotics is further bolstered by the availability of generic options, as companies strive to develop equivalents to branded macrolides, enhancing their market presence.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Macrolide Antibiotics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Macrolide Antibiotics Market Segmental Analysis

Global Macrolide Antibiotics Market is segmented by Drugs, Administration, Indication, End User and region. Based on Drugs, the market is segmented into Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin. Based on Administration, the market is segmented into Oral and Parenteral. Based on Indication, the market is segmented into Infection due to mycoplasma pneumonia, Legionella sp,or Bordetella pertussis, Symptomatic cat-scratch disease, Bacillary angiomatosis, Peliosis hepatis in patients with AIDS, Cebebral taxoplasmosis, Uncomplicated skin infection and Others. Based on End User, the market is segmented into Hospitals, Dermatology clinics, Pharmaceutical companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Macrolide Antibiotics Market

The global macrolide antibiotics market is experiencing significant growth driven by emerging trends in developing nations such as China, India, and Brazil. These markets present substantial opportunities due to their large populations and increasing healthcare expenditures, which contribute to a rising demand for antibiotics. As bacterial infections become more prevalent in these regions, the need for effective treatment solutions continues to escalate. Consequently, manufacturers of macrolide antibiotics can expand their market presence and capitalize on the growing demand for innovative and efficient alternatives. This combination of factors positions the macrolide antibiotics market for remarkable expansion in the coming years.

Restraints in the Global Macrolide Antibiotics Market

The Global Macrolide Antibiotics market faces significant constraints due to the increasing prevalence of antibiotic-resistant microorganisms, particularly to macrolides. This resistance primarily arises from the overuse and misuse of antibiotics, posing a critical challenge to the long-term viability of macrolide treatments for bacterial infections. As the effectiveness of these drugs diminishes, the market potential for macrolide antibiotics is compromised. Addressing the escalating issue of antibiotic resistance necessitates the development of new pharmacological options and alternative therapeutic strategies to ensure effective treatment and mitigate the impact of resistant bacteria on public health.

Market Trends of the Global Macrolide Antibiotics Market

The Global Macrolide Antibiotics market is increasingly shaped by the urgent need to address bacterial resistance and enhance treatment efficacy. Pharmaceutical companies are innovating to develop new macrolide derivatives and advanced formulations, focusing on improving pharmacokinetics and expanding their spectrum of activity. This trend reflects a commitment to counteract evolving microbial threats while optimizing existing macrolide treatments for a wide range of bacterial infections. Additionally, increasing awareness of antibiotic resistance is driving research investments, suggesting a dynamic market landscape poised for growth. Consequently, the macrolide antibiotic sector is adapting to meet the pressing challenges posed by resistant pathogens in the healthcare environment.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Macrolide Antibiotics Market Size by Drugs & CAGR (2025-2032)

Global Macrolide Antibiotics Market Size by Administration & CAGR (2025-2032)

Global Macrolide Antibiotics Market Size by Indication & CAGR (2025-2032)

Global Macrolide Antibiotics Market Size by End User & CAGR (2025-2032)

Global Macrolide Antibiotics Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기